The artificial vital organs and medical bionics market is expected to escalate at a CAGR of 8.7%, from USD 46.4 billion in 2022 to USD 107.4 billion through 2032.
The sudden emergence of the COVID-19 pandemic prompted the imposition of strict
The artificial vital organs and medical bionics market is expected to escalate at a CAGR of 8.7%, from USD 46.4 billion in 2022 to USD 107.4 billion through 2032.
The sudden emergence of the COVID-19 pandemic prompted the imposition of strict